Nipro Medical Corporation, the Japanese leader in the healthcare and medical device industry, is consolidating its presence in Morocco. Its subsidiary, based in Casablanca since 2020, has succeeded in accelerating its market deployment dynamic with the establishment of a logistics platform in line with international standards, designed to supply Nipro Medical solutions with its complete renal range for water treatment rooms and dialysis generators.
« The leitmotiv of our local presence in the Moroccan market as a subsidiary of Nipro Medical Europe & Middle East Africa is to be able to offer the latest technologies capable of contributing to continuous improvement in the quality of care and treatment results for dialysis patients in public, private and association dialysis centers », explains Sara Laafou, General Manager of Nipro Medical Morocco and Côte d’Ivoire.
In addition to providing solutions for healthcare professionals and dialysis patients, Nipro Medical Morocco is also involved in organizing scientific conferences and round tables for the nephrology community, to discuss the latest developments in innovative care, research and training in nephrology.
« Continuing education and the sharing of innovations with the ecosystem of healthcare professionals, particularly in dialysis, is at the heart of our strategy to help improve the quality of care for dialysis patients in line with our global motto ‘live longer, live better' », adds Sara Laafou.
The dialysis market in Morocco is segmented between the public, associative and private sectors. The total consumables market is estimated at over 4 billion dirhams, covering 58% of the needs of the private dialysis market in Morocco. The remainder is covered by the public health sector (34%) and the voluntary sector (8%).
Sara Laafou: the « Sanpo Yoshi » activist
A single heartbeat made in Japan drives the daily life of Sara Laafou, manager of Nipro Medical EMEA’s Morocco and Côte d’Ivoire subsidiary, the « Sanpo Yoshi ». « This principle at the heart of our parent company’s culture is based on responsibility in business. It translates into ‘three benefits’ for ‘the three winning parties’, i.e. the patient, the practitioner and the Nipro company », explains the young Moroccan manager, who has been proving herself in the medical field since 2007 before taking the helm at Nipro Medical EMEA.
A graduate of ENCG and holder of a Master’s degree in marketing and communications from ISCAE, Sara Laafou was promoted to manager of the Ivorian market in 2024. A promotion that reinforces the Japanese firm’s development strategy on the African continent by making its Moroccan subsidiary the bridgehead for Africa.
Sara Laafou‘s LinkedIn profile
About Nipro Corporation Japan
Headquartered in Osaka, Nipro Corporation Japan (NCJ) has been a world leader in medical, pharmaceutical and glass products since 1954. It operates in the cardiology, nephrology, endocrinology and pharmapackaging sectors, among others. With a presence on five continents and 38,000 employees, NCJ is expected to generate global sales in excess of $6 billion by 2023.
